BrightView (BV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Jan, 2026Executive summary
Annual meeting scheduled for March 3, 2026, at 11:00 AM ET, accessible virtually for all shareholders.
Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online, with options for paper or email copies upon request.
Voting can be conducted online, by phone, or at the virtual meeting, with a deadline of March 2, 2026, at 11:59 PM ET for advance voting.
Voting matters and shareholder proposals
Election of directors, with nominees: James R. Abrahamson, Dale A. Asplund, Jane Okun Bomba, William Cornog, Frank Lopez, Paul E. Raether, Mara Swan, Kurtis Barker, and Joshua Goldman.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal 2026.
Board recommends voting "FOR" all director nominees and "FOR" the auditor ratification proposal.
Provision to transact other business as may properly come before the meeting or any adjournments.
Board of directors and corporate governance
Director nominees include a mix of current and new candidates, reflecting board continuity and potential refreshment.
Shareholders can withhold authority for individual nominees if desired.
Latest events from BrightView
- Profitable growth driven by scale, recurring revenue, and transformation in a $140B market.BV
Investor presentation16 Mar 2026 - Revenue up 2.6%-3% to $615M, net loss widens, guidance reaffirmed for 2026.BV
Q1 20264 Feb 2026 - Record EBITDA, margin gains, and debt reduction drive raised free cash flow guidance.BV
Q3 20242 Feb 2026 - Director elections, auditor ratification, and robust governance highlight the 2026 proxy.BV
Proxy Filing15 Jan 2026 - Record Adjusted EBITDA, margin gains, and lower leverage set stage for continued growth.BV
Q4 202414 Jan 2026 - Targeting ~$4B revenue and 16%+ EBITDA margin by 2030 through unified strategy and efficiencies.BV
Investor Day 202527 Dec 2025 - Adjusted EBITDA up 11.6% and margin expands despite 4.4% revenue decline in Q1 2025.BV
Q1 202518 Dec 2025 - Major investors may sell preferred and common shares; Series A Preferred Stock offers 7% yield and conversion rights.BV
Registration Filing16 Dec 2025 - Annual meeting covers director elections, auditor, executive pay, and major ESG initiatives.BV
Proxy Filing1 Dec 2025